Molecular Partners Ag (MOLN) Change in Intangibles (2021 - 2024)
Molecular Partners Ag (MOLN) posted quarterly Change in Intangibles of $18447.7 for Q3 2024, down 89.61% year-over-year from $177497.7 in Q4 2023, and up 204.33% quarter-over-quarter from -$17682.7 in Q2 2024.
Molecular Partners Ag (MOLN) Change in Intangibles (2021 - 2024) Analysis & Trends
Molecular Partners Ag (MOLN) has reported Change in Intangibles for 4 consecutive years, with $18447.7 the latest figure, recorded in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.68 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Molecular Partners Ag | 163.99 Mn | 163.99 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 18,447.69 |
| Sep 30, 2024 | 18,447.69 |
| Jun 30, 2024 | -17,682.74 |
| Jun 30, 2024 | -17,682.74 |
| Mar 31, 2024 | -10.31 |
| Mar 31, 2024 | -10.31 |
| Sep 30, 2023 | 177,497.75 |
| Sep 30, 2023 | 177,497.75 |
| Jun 30, 2023 | -174,505.90 |
| Jun 30, 2023 | -174,505.90 |
| Mar 31, 2023 | -102.71 |
| Mar 31, 2023 | -102.71 |
| Sep 30, 2022 | 113,715.92 |
| Sep 30, 2022 | 113,715.92 |
| Jun 30, 2022 | -114,245.46 |
| Jun 30, 2022 | -114,245.46 |
| Mar 31, 2022 | 34.65 |
| Mar 31, 2022 | 34.65 |
| Sep 30, 2021 | 200,142.72 |
| Sep 30, 2021 | 200,142.72 |